Online citations, reference lists, and bibliographies.
← Back to Search

ARGINASE: A CRITICAL REGULATOR OF NITRIC OXIDE SYNTHESIS AND VASCULAR FUNCTION

W. Durante, F. Johnson, R. A. Johnson
Published 2007 · Medicine, Biology

Cite This
Download PDF
Analyze on Scholarcy
Share
1 Arginase is the focal enzyme of the urea cycle hydrolysing l‐arginine to urea and l‐ornithine. Emerging studies have identified arginase in the vasculature and have implicated this enzyme in the regulation of nitric oxide (NO) synthesis and the development of vascular disease. 2 Arginase inhibits the production of NO via several potential mechanisms, including competition with NO synthase (NOS) for the substrate l‐arginine, uncoupling of NOS resulting in the generation of the NO scavenger, superoxide and peroxynitrite, repression of the translation and stability of inducible NOS protein, inhibition of inducible NOS activity via the generation of urea and by sensitization of NOS to its endogenous inhibitor asymmetric dimethyl‐l‐arginine. 3 Upregulation of arginase inhibits endothelial NOS‐mediated NO synthesis and may contribute to endothelial dysfunction in hypertension, ageing, ischaemia–reperfusion and diabetes. 4 Arginase also redirects the metabolism of l‐arginine to l‐ornithine and the formation of polyamines and l‐proline, which are essential for smooth muscle cell growth and collagen synthesis. Therefore, the induction of arginase may also promote aberrant vessel wall remodelling and neointima formation. 5 Arginase represents a promising novel therapeutic target that may reverse endothelial and smooth muscle cell dysfunction and prevent vascular disease.
This paper references
10.1096/fj.99-0960com
Physiological cyclic stretch directs L‐arginine transport and metabolism to collagen synthesis in vascular smooth muscle
W. Durante (2000)
10.1161/01.HYP.0000146907.82869.f2
Upregulation of Vascular Arginase in Hypertension Decreases Nitric Oxide–Mediated Dilation of Coronary Arterioles
C. Zhang (2004)
10.1016/S0378-1119(97)00099-1
Human type II arginase: sequence analysis and tissue-specific expression.
S. M. Morris (1997)
10.1074/jbc.272.48.30154
Lysophosphatidylcholine Regulates Cationic Amino Acid Transport and Metabolism in Vascular Smooth Muscle Cells
W. Durante (1997)
10.1021/AR040183K
Arginase: structure, mechanism, and physiological role in male and female sexual arousal.
D. Christianson (2005)
10.1161/01.CIR.103.8.1121
Transforming Growth Factor-β1 Stimulates l-Arginine Transport and Metabolism in Vascular Smooth Muscle Cells
W. Durante (2001)
10.1016/S0008-6363(96)00073-9
The role of nitric oxide and cell adhesion molecules on the microcirculation in ischaemia-reperfusion.
A. Lefer (1996)
Physiologic cyclic stretch directs l-arginine transport and metabolism to collagen synthesis in vascular smooth muscle cells
W Durante (2000)
10.2337/DIABETES.54.1.51
Growth hormone overexpression in the central nervous system results in hyperphagia-induced obesity associated with insulin resistance and dyslipidemia.
M. Bohlooly-Y (2005)
10.1042/BJ3360001
Arginine metabolism: nitric oxide and beyond.
G. Wu (1998)
l-Arginine improves endothelial-dependent vasorelaxation and reduces intimal hyperplasia after balloon injury
WC Tarry (1994)
10.1096/fj.03-0115fje
Ischemia‐reperfusion selectively impairs nitric oxide‐ mediated dilation in coronary arterioles: counteracting role of arginase
T. Hein (2003)
10.1016/S0006-291X(86)80333-3
Isolation of human liver arginase cDNA and demonstration of nonhomology between the two human arginase genes.
G. Dizikes (1986)
10.1172/JCI115937
Antiatherogenic effects of L-arginine in the hypercholesterolemic rabbit.
J. Cooke (1992)
10.1016/J.ATHEROSCLEROSIS.2004.09.006
Accumulated endogenous nitric oxide synthase inhibitors, enhanced arginase activity, attenuated dimethylarginine dimethylaminohydrolase activity and intimal hyperplasia in premenopausal human uterine arteries.
Renzo Y. Loyaga-Rendon (2005)
10.1016/S0033-0620(05)80001-5
Nitric oxide and its role in the cardiovascular system.
J. Loscalzo (1995)
Increased expression of arginase II in patients with different forms of arthritis. Implications of the regulation of nitric oxide.
I. Corraliza (2002)
10.1152/AJPHEART.1996.271.5.H1988
Arginase activity in endothelial cells: inhibition by NG-hydroxy-L-arginine during high-output NO production.
G. Buga (1996)
10.1152/AJPCELL.2000.279.1.C248
IL-4 and IL-13 upregulate arginase I expression by cAMP and JAK/STAT6 pathways in vascular smooth muscle cells.
L. Wei (2000)
10.1152/AJPREGU.00758.2004
Arginase inhibition restores arteriolar endothelial function in Dahl rats with salt-induced hypertension.
F. Johnson (2005)
10.1055/S-2000-13210
Asymmetric dimethylarginine, derangements of the endothelial nitric oxide synthase pathway, and cardiovascular diseases.
R. Böger (2000)
10.1152/AJPLUNG.00194.2003
Arginase inhibition increases nitric oxide production in bovine pulmonary arterial endothelial cells.
L. Chicoine (2004)
Dysregulated arginine metabolism, hemolysis-associated pulmonary hypertension, and limited substrate availability in sickle cell disease
CR Morris (2005)
10.1152/ajpheart.1998.274.1.H342
Arginase modulates nitric oxide production in activated macrophages.
Chiung-I Chang (1998)
10.1128/MCB.21.3.811-813.2001
Generation of a Mouse Model for Arginase II Deficiency by Targeted Disruption of the Arginase II Gene
O. Shi (2001)
10.1073/pnas.0735876100
Translational control of inducible nitric oxide synthase expression by arginine can explain the arginine paradox
J. Lee (2003)
Arginase induces endothelial dysfunction and hypertension in obese Zucker rats
W Durante (2005)
10.1177/0148607186010002227
Arginine: biochemistry, physiology, and therapeutic implications.
A. Barbul (1986)
Arginase inhibition reduced endothelial dysfunction and blood pressure rising in spontaneously hypertensive rats
C Demougeot (2005)
10.4049/jimmunol.171.9.4561
Translational Control of Inducible Nitric Oxide Synthase by IL-13 and Arginine Availability in Inflammatory Macrophages 1
Stefan El-Gayar (2003)
10.1016/0305-0491(95)02138-8
Comparative properties of arginases.
C. P. Jenkinson (1996)
10.1081/CEH-100100063
INCREASED ARGINASE ACTIVITY IN AORTA OF MINERALOCORTICOID-SALT HYPERTENSIVE RATS
S. Rodriguez (2000)
Urea inhibits nitric oxide synthase in macrophage cell line
SS Prabhakar (1997)
10.1016/0140-6736(91)92372-9
Correction of endothelial dysfunction in coronary microcirculation of hypercholesterolaemic patients by L-arginine
H. Drexler (1991)
10.1006/NIOX.1999.0255
Effects of the new arginase inhibitor N(omega)-hydroxy-nor-L-arginine on NO synthase activity in murine macrophages.
J. Tenu (1999)
10.1074/JBC.M404044200
Three Different Oxygen-induced Radical Species in Endothelial Nitric-oxide Synthase Oxygenase Domain under Regulation by L-Arginine and Tetrahydrobiopterin*
V. Berka (2004)
Transforming growth factor-b1 stimulates l-arginine transport and metabolism in vascular smooth muscle cells: Role in polyamine and collagen synthesis
W Durante (2001)
10.1038/sj.ijir.3900849
Increased expression of arginase II in human diabetic corpus cavernosum: in diabetic-associated erectile dysfunction
T. Bivalacqua (2002)
10.1159/000020660
Arginase in Glomerulonephritis
S. Waddington (2000)
Upregulation of vascular arginase in
C Zhang
10.1161/01.HYP.0000198543.34502.d7
Knockdown of Arginase I Restores NO Signaling in the Vasculature of Old Rats
A. White (2006)
10.1165/RCMB.2005-0039OC
Cytokine-induced endothelial arginase expression is dependent on epidermal growth factor receptor.
L. Nelin (2005)
Complete nucleotide sequence of cDNA and deduced amino acid sequence of rat liver arginase.
S. Kawamoto (1987)
10.1096/fj.01-0260com
α‐Lipoic acid inhibits TNF‐a‐induced NF‐κB activation and adhesion molecule expression in human aortic endothelial cells
W. Zhang (2001)
10.1152/ajpcell.1997.273.6.C1882
Urea inhibits inducible nitric oxide synthase in macrophage cell line.
S. S. Prabhakar (1997)
10.1038/333664A0
Vascular endothelial cells synthesize nitric oxide from L-arginine
R. M. Palmer (1988)
10.1096/fj.00-0681fje
Constitutive expression of arginase in microvascular endothelial cells counteracts nitric oxide‐mediated vasodilatory function
C. Zhang (2001)
10.1097/01.hjh.0000166837.78559.93
Arginase inhibition reduces endothelial dysfunction and blood pressure rising in spontaneously hypertensive rats
C. Demougeot (2005)
10.1016/S0165-6147(03)00227-X
Arginase and asthma: novel insights into nitric oxide homeostasis and airway hyperresponsiveness.
H. Meurs (2003)
10.1074/jbc.271.20.11838
Platelet-derived Growth Factor Regulates Vascular Smooth Muscle Cell Proliferation by Inducing Cationic Amino Acid Transporter Gene Expression (*)
W. Durante (1996)
10.1152/AJPHEART.01104.2005
Modulation of contractility by myocyte-derived arginase in normal and hypertrophied feline myocardium.
A. Jung (2006)
10.1191/1358863x02vm434ra
L-Arginine in cardiovascular disease: dream or reality?
D. Tousoulis (2002)
10.1164/RCCM.200502-253OC
Increased arginase activity in cystic fibrosis airways.
H. Grasemann (2005)
10.1006/GENO.1996.0606
Cloning and characterization of the human type II arginase gene.
J. Vockley (1996)
10.1046/J.1523-1747.2003.12610.X
Expression and activity of arginase isoenzymes during normal and diabetes-impaired skin repair.
H. Kämpfer (2003)
10.1096/fj.04-2317fje
Increased arginase II and decreased NO synthesis in endothelial cells of patients with pulmonary arterial hypertension
W. Xu (2004)
10.1161/01.CIR.0000092948.04444.C7
Arginase Reciprocally Regulates Nitric Oxide Synthase Activity and Contributes to Endothelial Dysfunction in Aging Blood Vessels
D. Berkowitz (2003)
10.1016/J.YJMCC.2004.05.004
Arginase pathway in human endothelial cells in pathophysiological conditions.
T. Bachetti (2004)
The role of nitric oxide and cell adhesion molecules on the microcirculation in ischemia–reperfusion
DJ LeferAm.Lefer (1996)
10.1161/01.RES.83.2.217
Thrombin stimulates vascular smooth muscle cell polyamine synthesis by inducing cationic amino acid transporter and ornithine decarboxylase gene expression.
W. Durante (1998)
10.1172/JCI13848
An experiment of nature: genetic L-arginine deficiency and NO insufficiency.
J. Loscalzo (2001)
10.1016/S0008-6363(02)00410-8
Carbon monoxide inhibits apoptosis in vascular smooth muscle cells.
X. Liu (2002)
10.1016/J.CARPATH.2004.03.131
Abstract 464: Arginase Promotes Vascular Smooth Muscle Cell Proliferation and Neointima Formation
W. Durante (2004)
10.1161/01.ATV.14.6.938
L-arginine improves endothelium-dependent vasorelaxation and reduces intimal hyperplasia after balloon angioplasty.
W. C. Tarry (1994)
10.1038/sj.bjp.0701143
Inhibition of arginase in rat and rabbit alveolar macrophages by Nω‐hydroxy‐D,L‐indospicine, effects on L‐arginine utilization by nitric oxide synthase
C. Hey (1997)
10.1152/AJPENDO.2001.280.1.E75
Regulatory role of arginase I and II in nitric oxide, polyamine, and proline syntheses in endothelial cells.
H. Li (2001)
10.1152/PHYSREV.1990.70.3.701
Nitrogen metabolism and ornithine cycle function.
A. Meijer (1990)
10.1016/J.YMGME.2004.11.004
Hyperargininemia due to liver arginase deficiency.
E. Crombez (2005)
10.1073/pnas.161294898
Elevated arginase I expression in rat aortic smooth muscle cells increases cell proliferation
L. Wei (2001)
10.1007/S11906-003-0021-1
Potential mechanisms of impaired endothelial function in arterial hypertension and hypercholesterolemia
S. John (2003)
Platelet-derived growth factor regulates vascular smooth muscle cell proliferation by inducing cationic amino acid transporter gene expression in cultured vascular smooth muscle cells
W Durante (1996)
10.1385/CBB:35:1:19
Regulation of L-arginine transport and metabolism in vascular smooth muscle cells
W. Durante (2007)
10.1152/AJPLUNG.2001.281.5.L1232
Cytokine treatment increases arginine metabolism and uptake in bovine pulmonary arterial endothelial cells.
L. Nelin (2001)
10.1128/MCB.22.13.4491-4498.2002
Mouse Model for Human Arginase Deficiency
R. Iyer (2002)
10.1016/S0002-9440(10)63811-4
Arginase 1 overexpression in psoriasis: limitation of inducible nitric oxide synthase activity as a molecular mechanism for keratinocyte hyperproliferation.
D. Bruch-Gerharz (2003)
10.1161/01.CIR.0000142867.26182.32
Thrombin Stimulates Human Endothelial Arginase Enzymatic Activity via RhoA/ROCK Pathway: Implications for Atherosclerotic Endothelial Dysfunction
X. Ming (2004)
Polyamines
W Durante (1984)
10.1152/AJPHEART.1991.261.1.H15
Agents that modify EDRF formation alter antiplatelet properties of brain arteriolar endothelium in vivo.
H. Nishimura (1991)
10.1006/BBRC.1994.2371
N omega-hydroxyl-L-arginine, an intermediate in the L-arginine to nitric oxide pathway, is a strong inhibitor of liver and macrophage arginase.
J. L. Boucher (1994)
10.1001/JAMA.294.1.81
Dysregulated arginine metabolism, hemolysis-associated pulmonary hypertension, and mortality in sickle cell disease.
C. Morris (2005)
10.1093/JN/130.11.2626
Arginine nutrition and cardiovascular function.
G. Wu (2000)
Inhibition of arginase in rat and rabbit alveolar macrophages by © 2007 Blackwell Publishing Asia Pty Ltd N w -hydroxy-d,1-indospicine, effects of l-arginine utilization by nitric oxide synthase
C Hey (1997)
10.1016/0022-4804(91)90054-P
Intimal hyperplasia is reduced by ornithine decarboxylase inhibition.
E. Endean (1991)
10.1016/S1567-5688(06)80779-8
Identification of macrophage arginase I as a new candidate gene of atherosclerosis resistance.
D. Teupser (2006)
10.1073/pnas.071054698
Role of the arginine-nitric oxide pathway in the regulation of vascular smooth muscle cell proliferation
L. Ignarro (2001)



This paper is referenced by
10.1111/j.1743-6109.2010.02098.x
Arginase II deletion increases corpora cavernosa relaxation in diabetic mice.
H. Toque (2011)
10.1007/978-3-030-45328-2_3
Amino Acids in Circulatory Function and Health.
W. Durante (2020)
10.5772/39140
The Role Erectile Dysfunction Plays in Cardiovascular Diseases
S. Crestani (2012)
10.3389/fphys.2017.00249
Nitric Oxide Synthase Activity Correlates with OGG1 in Ozone-Induced Lung Injury Animal Models
S. Zhang (2017)
Aus der Klinik für Kardiologie, Pneumologie und Angiologie der Heinrich-Heine-Universität Düsseldorf
M. Kelm (2013)
10.1152/ajplung.00183.2009
Hypoxia promotes human pulmonary artery smooth muscle cell proliferation through induction of arginase.
B. Chen (2009)
10.1073/pnas.1307058110
Arginase regulates red blood cell nitric oxide synthase and export of cardioprotective nitric oxide bioactivity
J. Yang (2013)
10.1016/j.pupt.2011.01.009
Up-regulation of arginase II contributes to pulmonary vascular endothelial cell dysfunction during experimental pulmonary embolism.
J. A. Watts (2011)
10.1111/j.1464-410X.2012.11529.x
Arginase enzymes in the human prostate: expression of arginase isoenzymes and effects of arginase inhibitors on isolated human prostate tissue
George T. Kedia (2012)
Acute cerebellar infarcts in a young woman with beta-thalassemia major.
I. Cojocaru (2011)
10.1016/j.pharmthera.2010.02.005
Modulating the NO generating system from a medicinal chemistry perspective: current trends and therapeutic options in cardiovascular disease.
D. Schade (2010)
10.1371/journal.pone.0022460
Arginase 2 Deletion Reduces Neuro-Glial Injury and Improves Retinal Function in a Model of Retinopathy of Prematurity
S. P. Narayanan (2011)
10.1152/japplphysiol.90627.2008
Arginase and vascular aging.
L. Santhanam (2008)
Can glycated hemoglobin be a biomarker for iatrogenic pancreatic iron deposition due to repeated blood transfusion in â thalassemia major? A pilot study in north indian population
Megha Kataria Arora (2014)
In Vivo Evaluation of Bcl-xl, Foxo3, ARG1, and miR-144/451 Genes in Response to Oxidative Stress Induced by Hydroxyurea in β-Thalassemia Major Patients
A. Azarkeivan (2019)
Molecular Basis of Disrupted Polyamine Metabolism in Diabetes and Effects of Triethylenetetramine
Jennifer Sweny (2014)
10.3390/cancers12092349
Caveolin-1-Mediated Tumor Suppression Is Linked to Reduced HIF1α S-Nitrosylation and Transcriptional Activity in Hypoxia
C. Sanhueza (2020)
10.1111/and.13349
Arginase enzymes in the human prostate: A molecular biological and immunohistochemical approach
H. Rahardjo (2019)
10.1213/XAA.0000000000000066
Anesthetic management of a patient with arginase deficiency undergoing liver transplantation.
H. Mace (2014)
10.1002/cphy.c130015
Cutaneous vasodilator and vasoconstrictor mechanisms in temperature regulation.
J. M. Johnson (2014)
10.3390/nu11020225
Evidence that Nitric Oxide is Involved in the Blood Pressure Lowering Effect of the Peptide AVFQHNCQE in Spontaneously Hypertensive Rats
Anna Mas-Capdevila (2019)
10.1161/ATVBAHA.108.183392
Arginase Promotes Neointima Formation in Rat Injured Carotid Arteries
K. Peyton (2009)
10.1159/000350283
What's New in the Pathophysiology of Sickle Cell Disease?
A. Adekile (2013)
10.1007/s11010-010-0515-5
Endothelial arginase II responds to pharmacological inhibition by elevation in protein level
Karina Y Krotova (2010)
Glucose as a factor of importance for regulating arginase activity in red blood cells
Pétur Rafnsson (2014)
10.1093/intimm/dxaa019
Amino acids: key sources for immunometabolites and immunotransmitters.
Michio Miyajima (2020)
10.1371/journal.pone.0103260
Effect of Arginase Inhibition on Ischemia-Reperfusion Injury in Patients with Coronary Artery Disease with and without Diabetes Mellitus
O. Kövamees (2014)
10.1155/2020/4935386
Norvaline Reduces Blood Pressure and Induces Diuresis in Rats with Inherited Stress-Induced Arterial Hypertension
M. A. Gilinsky (2020)
10.1186/s12871-016-0288-9
Erratum to: The effects of arginase inhibitor on lung oxidative stress and inflammation caused by pneumoperitoneum in rats
J. S. Cho (2016)
10.1371/journal.pone.0156793
Biphasic Effect of Diabetes on Neuronal Nitric Oxide Release in Rat Mesenteric Arteries
E. Sastre (2016)
10.1152/japplphysiol.00503.2010
Acute L-arginine supplementation reduces the O2 cost of moderate-intensity exercise and enhances high-intensity exercise tolerance.
S. Bailey (2010)
10.1021/acs.jmedchem.6b00810
Design, Synthesis, and Bioactivation of O-Glycosylated Prodrugs of the Natural Nitric Oxide Precursor N(ω)-Hydroxy-l-arginine.
Felix-A Litty (2016)
See more
Semantic Scholar Logo Some data provided by SemanticScholar